ReviewTransplantation and cellular therapy2024

Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.

Lacey S Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.